Insider Trading: EnteroMedics Inc (ETRM.W)
ETRM.W on CBOE When Trading NASDAQ Global Select Market
1.05USD
17 May 2013
1.05USD
17 May 2013
Price Change (% chg)
$0.19 (+22.08%)
$0.19 (+22.08%)
Prev Close
$0.86
$0.86
Open
$1.10
$1.10
Day's High
$1.10
$1.10
Day's Low
$1.03
$1.03
Volume
1,900
1,900
Avg. Vol
76
76
52-wk High
$4.34
$4.34
52-wk Low
$0.84
$0.84
| WHITEBOX ADVISORS L L C | Options Exercised: 0 | ||
| Trade Date: | Tuesday, 8 Nov 2011 | Price: | 1.90 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 2,575,871 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | -600 |
Institutional Holders
| % Shares Owned: | 48.28% |
| # of Holders: | 70 |
| Total Shares Held: | 26,850,001 |
| 3 Mo. Net Change: | -1,148,753 |
| # New Positions: | 15 |
| # Closed Positions: | 17 |
| # Increased Positions: | 44 |
| # Reduced Positions: | 30 |
| # Net Buyers: | 14 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Mark Knudson |
64 | 2002 | Chairman of the Board, President, Chief Executive Officer |
Gregory Lea |
60 | 2013 | Chief Financial Officer, Chief Operating Officer, Senior Vice President |
Adrianus Donders |
59 | 2005 | Senior Vice President - Research and Advanced Development |
Katherine Tweden |
52 | 2011 | Vice President - Clinical and Regulatory |
Anthony Jansz |
51 | 2011 | Director |
Luke Evnin |
2002 | Independent Director | |
Catherine Friedman |
51 | 2007 | Independent Director |
Carl Goldfischer |
53 | 2004 | Independent Director |
Bobby Griffin |
74 | 2006 | Independent Director |
Paul Klingenstein |
2006 | Independent Director | |
Nicholas Teti |
59 | 2007 | Independent Director |
Jon Tremmel |
66 | 2009 | Independent Director |

